Related content

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

By Formelli Franca   Cavadini Elena   Luksch Roberto   Garaventa Alberto   Villani Maria   Appierto Valentina   Persiani Stefano  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 655-665

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer

By Turner P.   Houghton Janet   Petak Istvan   Tillman David   Douglas Leslie   Schwartzberg Lee   Billups Catherine   Panetta John   Stewart Clinton  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 253-260

Springer Publishing Company

Access to resources Recommend Favorite

Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-01 ,pp. : 195-200

Science Publishers

Access to resources Recommend Favorite

The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide

By Armstrong Jane L.   Martin Shaun   Illingworth Nicola A.   Jamieson David   Neilson Abbie   Lovat Penny E.   Redfern Chris P.F.   Veal Gareth J.  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 293-298

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

By Jiko Mari   Yano Ikuko   Sato Eriko   Takahashi Kazushige   Motohashi Hideyuki   Masuda Satohiro   Okuda Masahiro   Ito Noriyuki   Nakamura Eijiro   Segawa Takehiko   Kamoto Toshiyuki   Ogawa Osamu   Inui Ken-ichi  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite